Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the bloodstream infection testing market and it is poised to grow by $ 3.56 bn during 2021-2025, progressing at a CAGR of over 8% during the forecast period. Our report on bloodstream infection testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing hospital visits and growing government regulations increasing blood donation awareness.
The bloodstream infection testing market analysis includes technology segment and geographic landscape.
The bloodstream infection testing market is segmented as below:
By Technology
- Conventional testing
- Non-conventional testing
By Geography
- North America
- Europe
- Asia
- ROW
This study identifies the unmet needs in developing countries as one of the prime reasons driving the bloodstream infection testing market growth during the next few years.
The report on bloodstream infection testing market covers the following areas:
- Bloodstream infection testing market sizing
- Bloodstream infection testing market forecast
- Bloodstream infection testing market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bloodstream infection testing market vendors that include Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Also, the bloodstream infection testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global bloodstream infection testing market: Abbott Laboratories, Accelerate Diagnostics Inc., Becton, Dickinson and Co., bioMerieux SA, Bruker Corp., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Siemens Healthineers AG, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the unmet needs in developing countries.`
According to the report, one of the major drivers for this market is the increasing hospital visits.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Accelerate Diagnostics Inc.
- Becton
- Dickinson and Co.
- bioMerieux SA
- Bruker Corp.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Grifols SA
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
